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Interacting proteins typically coevolve, and the
identification of coevolving amino acids can pinpoint
residues required for interaction specificity. This
approach often assumes that an interface-disrupting
mutation in one protein drives selection of a compen-
satory mutation in its partner during evolution.
However, this model requires a non-functional inter-
mediate state prior to the compensatory change.
Alternatively, a mutation in one protein could first
broaden its specificity, allowing changes in its part-
ner, followed by a specificity-restricting mutation.
Using bacterial toxin-antitoxin systems, we demon-
strate the plausibility of this second, promiscuity-
basedmodel. By screening large libraries of interface
mutants, we show that toxins and antitoxins with
high specificity are frequently connected in sequence
space to more promiscuous variants that can serve
as intermediates during a reprogramming of interac-
tion specificity. We propose that the abundance of
promiscuous variants promotes the expansion and
diversification of toxin-antitoxin systems and other
paralogous protein families during evolution.
INTRODUCTION
Many interacting proteins within the same cell, particularly
signaling proteins, are members of large paralogous families
that have expanded through duplication and divergence. To
expand in number, paralogous interacting proteins typically
must become specific after duplication to avoid unwanted
cross-talk (Capra et al., 2012; Zarrinpar et al., 2003). The speci-
ficity determinants of protein-protein interactions remain poorly
defined in most systems. Even in the cases where they have
been identified, we lack a detailed understanding of how a
new, insulated protein-protein interaction emerges during the
course of evolution and,more generally, themutational paths fol-
lowed during protein evolution (DePristo et al., 2005).
Computational studies demonstrate that interacting proteins
often coevolve. Indeed, identification of coevolving residues
has helped guide identification of the specificity determinants
of many protein-protein interfaces (Ovchinnikov et al., 2014;594 Cell 163, 594–606, October 22, 2015 ª2015 Elsevier Inc.Skerker et al., 2008). The implicit notion or underlying model
behind these analyses is usually that an interaction-disrupting
mutation in one protein can be rescued by a mutation in its part-
ner (Figure 1A). This model, which we call the compensatory
mutation model, implies that the system passes through a non-
functional or non-interacting state. However, such a state is
highly unlikely, particularly for a protein-protein interaction that
is critical for the viability of an organism. Alternatively, the spec-
ificity of a given protein-protein interaction could change, and
become insulated from other paralogous systems, if one of the
proteins passes through a promiscuous intermediate (Figure 1B).
In this model, an initial mutation in protein A would broaden its
specificity, enabling its partner, protein B, to accumulate amuta-
tion that would have disrupted its interaction with the original,
ancestral form of protein A. A subsequent mutation in protein A
would then narrow its specificity to include the derived, but not
the ancestral, form of protein B. In this promiscuous intermediate
model, the specificities of the interacting proteins change
without ever transitioning through a non-functional intermediate
state. Note that in both models, A and B continue to interact
through the same set of interfacial residues and do not evolve
an alternative interface de novo (Kuriyan and Eisenberg, 2007).
Which of the two models in Figure 1 applies to most pairs of
interacting proteins is unclear. In each case, the mutational tra-
jectory involved would produce a signature of pairwise amino-
acid coevolution in the phylogenetic record. However, only the
latter, promiscuous intermediate model invokes the existence
of mutations that are transiently introduced to broaden the spec-
ificity of one of the two proteins. The prevalence of such promis-
cuous states is unknown, as is whether they are easily reached
from more specific, extant states.
Bacterial toxin-antitoxin (TA) systems provide an excellent
model system for dissecting the coevolutionary dynamics of pro-
tein-protein interactions. Originally identified on plasmids, these
systems are widely found in bacterial chromosomes, with many
species encoding multiple, paralogous copies that share exten-
sive similarity at the sequence and structural levels (Leplae et al.,
2011). The biological function of TA systems is unclear, but they
have been implicated in stress responses, resistance to phage,
formation of persister cells, and bacterial pathogenicity (Yama-
guchi et al., 2011). Typically, the toxin is a stable, globular protein
that can inhibit cell growth or viability unless antagonized by a
cognate antitoxin that directly binds and sequesters the toxin.
Changes in the degradation rate or synthesis of the antitoxin
can trigger release of the toxin. A toxin is typically encoded in
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Figure 1. Models for the Evolution of New Protein-Protein Interac-
tion Specificity
(A) In a model of coevolution through compensatory mutations, an initial mu-
tation in protein A that disrupts the A-B interaction is rescued by a compen-
satory mutation in protein B. Ovals represent the set of protein B variants that
are bound by protein A, and Xs indicate particular protein B variants. Note that
the intermediate state is a non-functional interaction.
(B) In an alternative model for protein coevolution, protein A first accumulates a
mutation that broadens its specificity, followed by a secondmutation in protein
B that retains its interaction with the new form of A but that would have dis-
rupted its interaction with the ancestral form of protein A. In a final step, protein
A mutates to narrow its specificity to include the derived, and not ancestral,
form of protein B.the same operon as an antitoxin, and toxin-antitoxin paralogs
frequently arise through operon duplications. An unresolved
question is whether toxin-antitoxin systems interact in an exclu-
sive one-to-one manner. Genetic data suggest that these inter-
actions may be specific (Fiebig et al., 2010), and the growth
inhibitory effects of a toxin are usually rescued only by express-
ing its co-operonic antitoxin (Hallez et al., 2010; Ramage et al.,
2009). However, interaction specificity has only been directly
tested in a limited number of cases, and some groups have sug-
gested that toxins and antitoxins encoded in different operons
are capable of interacting in vivo and in vitro, possibly forming
large, promiscuous networks (Yang et al., 2010; Zhu et al., 2010).
Here, we systematically measure the binding preferences of
20 ParD-ParE TA family members and find that these toxins
and antitoxins are highly specific, interacting almost exclusively
with their partner from the same operon. This specificity is en-
coded by a small set of coevolving residues at the toxin-antitoxin
interface, andmutations in these residues are sufficient to repro-
gram a ParD antitoxin to interact with non-cognate ParE toxins.
Guided by these findings, we generated a library with 104 var-
iants of the key, specificity-determining residues in a ParD anti-
toxin and selected mutants that antagonize the cognate toxin, a
non-cognate toxin, or both. Strikingly, we find that promiscuousvariants that antagonize multiple toxins are easily obtained and
are also highly connected in sequence space to specific variants.
These results suggest that mutational paths leading to changes
in toxin-antitoxin specificity are likely to involve promiscuous
intermediates. Such paths enable the reprogramming of toxin-
antitoxin specificity through the pairwise coevolution of interfa-
cial residues, but without passing through an intermediate state
that disrupts the protein-protein interaction. The abundance of
promiscuous states likely facilitates the evolutionary expansion
of these and other paralogous protein families following operon
and whole-genome duplications during evolution.
RESULTS
Toxins and Antitoxins from the ParDE Family Exhibit
High Interaction Specificity
To systematically measure the interaction specificity of TA sys-
tems, we focused on the ParD-ParE family, which is often found
in multiple copies on bacterial chromosomes (Fiebig et al., 2010;
Leplae et al., 2011) (Figure S1A). We initially cloned the three
chromosomally encoded ParD-ParE pairs from the a-proteo-
bacteriumMesorhizobium opportunistum into vectors that allow
for separate and inducible expression of the ParE toxin and ParD
antitoxin. To measure the interaction specificity for these pairs,
we then co-transformed all pairwise combinations of toxin and
antitoxin plasmids into E. coli and assessed whether the induced
expression of each ParD antitoxin rescues the growth arrest re-
sulting from inducing each ParE. As a control, we first confirmed
that inducing each ParE toxin inhibited growth of E. coli (Fig-
ure 2A). Then, plating on a medium that induces both ParD
and ParE, we observed growth for each of the three cognate
ParD-ParE pairings (Figure 2A). No growth was observed for
the six non-cognate pairs, indicating that the ParD antitoxins
from M. opportunistum can only neutralize their cognate ParE
toxins.
We extended this analysis to the 20 chromosomally encoded
ParDE pairs from eight different bacteria, including the three
pairs from M. opportunistum (Figure S1B). For this 20 3 20 ma-
trix of ParD and ParE pairs we observed strong interactions be-
tween all 20 co-operonic ParDE pairs, but only 11 of the 380 (or
3%) other possible pairings (Figure 2B). Importantly, these
cross-reactions were only observed between ParD and ParE
proteins not encoded in the same species, indicating that the
ParDE pairs within a given organism are typically insulated
from one another. These results indicate that ParD antitoxins
are highly specific for their cognate ParE toxins.
Identification of Covarying Residues in ParD and ParE
As a first step in understanding the molecular basis of specificity
in ParD-ParE complexes, we solved a 1.59-A˚ cocrystal structure
of the M. opportunistum ParD3 antitoxin bound to ParE3, its
cognate toxin. This structure revealed a heterotetrameric asym-
metric unit composed of ParD3 and ParE3 dimers (Figure S2A),
similar to a C. crescentus ParD-ParE structure (Dalton and
Crosson, 2010). Crystal packing and an estimated mass of
87 kDa in solution indicate that the biological assembly is
composed of two tetramers (Figures S2B and S2C). Within this
complex, each ParD3 subunit makes extensive contacts with aCell 163, 594–606, October 22, 2015 ª2015 Elsevier Inc. 595
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Figure 2. Toxins and Antitoxins from the
ParD-ParE Family Exhibit High Interaction
Specificity
(A) Testing of interaction specificity for ParD anti-
toxins and ParE toxins from Mesorhizobium op-
portunistum. Plasmids harboring the toxins and
antitoxins indicated were co-transformed into
E. coli with ParD and ParE induced as indicated.
(B) Comprehensive testing of interaction specificity
for 20 ParD and ParE pairs from eight different
species. Cells containing each possible ParD-ParE
pair were grown on plates that induce the toxin and
antitoxin, respectively, and grown overnight at
37C. Yellow, visible colonies following serial
dilution; black, no visible colonies.
See Figure S1.neighboring ParE3 subunit primarily through its second and third
alpha helices, with a total buried surface area of 1,624 A˚2
(Figure 3A).
Previous work with bacterial two-component signaling sys-
tems demonstrated that their interaction specificity is controlled
by a subset of residues at the protein-protein interface formed
by a histidine kinase and response regulator (Skerker et al.,
2008). These specificity-determining residues coevolve to main-
tain the interaction between cognate signaling proteins. Thus, to
pinpoint the residues that contribute to the specificity of ParD-
ParE interactions, we used GREMLIN, a pseudo-likelihood-596 Cell 163, 594–606, October 22, 2015 ª2015 Elsevier Inc.based model for coevolution (Kamisetty
et al., 2013; Ovchinnikov et al., 2014), to
search for residues that strongly covary
in a multiple sequence alignment of
concatenated, co-operonic ParD and
ParE proteins. This analysis identified 10
residues in ParD and 11 residues in
ParE that coevolve most strongly. Here-
after, we call these 21 amino acids
‘‘specificity’’ residues, as our work below
indicates that they play the dominant role
in determining partner specificity. Map-
ping these specificity residues onto the
ParD3-ParE3 crystal structure indicated
that they cluster into two groups at the
primary molecular interface formed by
these proteins (Figures 3B and 3C). The
first group sits at the base of the second
alpha helix in ParD3 and covaries with
residues in the three-stranded beta sheet
in ParE3. The second group clusters in
the third alpha helix in ParD3 and cova-
ries with residues in the first and second
alpha helices of ParE3. We also used
GREMLIN to identify residues within
each protein (four in ParD and six in
ParE) that coevolve with the specificity
residues (Figure 3C and S3A). These
‘‘supporting’’ residues may indirectly
contribute to ParD-ParE interaction spec-ificity by influencing the orientation or packing of the interfacial
specificity residues.
Covarying Residues Dictate Interaction Specificity
in the ParD-ParE Family
To determine whether the coevolving residues identified are suf-
ficient to dictate interaction specificity of the ParD-ParE family,
we constructed a series of chimeric proteins in which different
regions of the M. opportunistum ParD3 were replaced with the
corresponding regions of ParD1 or ParD2 (Figure S3B). Replac-
ing the entire C-terminal region of ParD3 with the corresponding
C D
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Figure 3. Covarying Residues Dictate Interaction Specificity in the ParD-ParE Family
(A) Structure of the M. opportunistum ParD3-ParE3 complex (PDB: 5CEG). Light orange, ParE3 monomer; light blue, ParD3 monomer.
(B) A section of the ParD3-ParE3 structure from (A) magnified; covarying residues shown in space-filling representation.
(C) Alignment of M. opportunistum ParD and ParE paralogs with coevolving residues highlighted in blue or orange for ParD or ParE, respectively. Supporting
residues, which coevolve with the interfacial coevolving residues, are highlighted in gray.
(D) Mutations in the C terminus of ParD3 can reprogram interaction specificity. The indicated ParD3 mutants were tested against each ParE homolog from
M. opportunistum using the E. coli toxicity-rescue assay.
Also see Figures S2 and S3.region of ParD1 or ParD2 produced a chimera that lost its ability
to interact with ParE3 but gained the ability to interact with ParE1
or ParE2 (Figure 3D). These chimeras involved both clusters of
interfacial residues identified as coevolving between ParD and
ParE proteins. Replacing only one of these clusters in the
ParD3 C terminus was sometimes sufficient to reprogram spec-
ificity, but depended on the toxin tested (Figure S3C). These re-
sults indicate that the C-terminal region of ParD, which contains
the specificity and supporting residues, is sufficient to dictate
interaction specificity.
To pinpoint the residues required for interaction specificity, we
focused additional mutagenesis on the coevolving residues
identified computationally. We generated variants of ParD3 in
which all of the specificity and supporting residues were re-
placed with the corresponding residues in ParD1 or ParD2, for
a total of 8 or 9 substitutions, respectively. In each case, we
found that these mutations were sufficient to reprogram ParD3
to interact with ParE1 or ParE2 and lose its ability to interactwith ParE3 (Figure 3D). Interestingly, ParD3 could be reprog-
rammed to interact with ParE1 or ParE2 with fewer substitutions.
For example, we found sets of four substitutions that were suffi-
cient to reprogram ParD3 to interact with ParE1 or ParE2 (Fig-
ure 3D). Taken together, our results indicate that mutating the
most highly coevolving residues in an antitoxin can be sufficient
to reprogram its interaction specificity, and, in some cases,
mutating only a subset of these residues allows a complete
switch in partner specificity.
High-Throughput Mapping of Interface Mutant Fitness
The results presented above indicate that antitoxin interaction
specificity can be reprogrammed by changing just four residues.
But how does specificity change as these four individual substi-
tutions are introduced and does the substitution order matter?
Does the specificity of antagonizing one ParE toxin to another
change abruptly, or are there promiscuousmutational intermedi-
ates? To answer these questions, we sought to generate a largeCell 163, 594–606, October 22, 2015 ª2015 Elsevier Inc. 597
library of ParD3 variants that included combinations of residues
shown to be specific for antagonizing ParE3 or ParE2, as well as
themutational intermediates separating these specific states. To
this end, we generated a library of mutants at four of the key
interfacial positions in the ParD3 antitoxin, Leu59, Trp60, Asp61,
and Lys64 (LWDK). To reduce the complexity of our library, we
only allowed residues at each library position that are commonly
found in naturally occurring ParD homologs (see Experimental
Procedures). The resulting library has a theoretical diversity of
9,360 variants, with 12, 6, 13, and 10 possible residues encoded
at the four respective positions of the library (Figure 4A). Deep-
sequencing of the relevant region in parD3 in the initial library re-
vealed that >98% of the predicted variants were represented by
at least 10 reads and >94% had at least 100 reads (Figure S4A).
Measurements of read numbers were highly reproducible be-
tween replicates (R2 > 0.99, Figure S4B).
To assess the ability of each ParD3 variant to bind and antag-
onize ParE3, we co-transformed E. coli with the ParD3 library
and an inducible ParE3 vector. When cultured in conditions
that do not induce ParD3, cell growth arrested within 200 min
after inducing the ParE3 toxin (Figure 4B). In contrast, when
the ParD3 library was expressed, growth slowed after inducing
the toxin but eventually resumed, suggesting that some fraction
of the population could neutralize ParE3 toxicity (Figure 4B). To
determine which mutants neutralized ParE3 and hence were
enriched during the course of this experiment, we harvested
samples every 100 min and deep-sequenced the relevant re-
gion of parD3. We observed large changes in the frequency
of individual variants over this time course (Figure S4C). For
example, the variant containing the wild-type ParD3 residues
(LWDK) was enriched 6-fold, whereas variants with frameshift
mutations in parD3, which are presumably non-functional, were
depleted 7-fold (Figure S4C). To validate the functionality of
variants inferred from this competitive growth assay, we iso-
lated six mutants that exhibited different frequency dynamics
following toxin induction (Figure 4C). We tested these six mu-
tants individually using our toxicity-rescue assay and found
clear agreement between the change in the frequency of
each variant in the library and its individual plating efficiency
(Figure 4D).
To quantify differences in variant behavior during competitive
growth, we generated a linear fit to the frequencies of each
mutant as a function of time, and then calculated the log-fold
expansion of each mutant relative to the rest of the population,
producing a raw fitness value (Wraw) for each mutant. We then
transformed these raw fitness values such that the W value for
frameshift variants was 0 and the W value for the wild-type
(LWDK) sequence was 1; the resulting distribution of W values
ranged from 0.04 to 1.13 and was highly reproducible be-
tween biological replicates (Figure 4E, R2 = 0.98). We found a
total of 252 variants with W values > 0.5, representing 2.7%
of the total (Figure 4F). This set included the wild-type combi-
nation of residues (LWDK) and 31 single, 189 double, and 31
triple mutants relative to the wild-type sequence (Figure S4D).
There were no quadruple mutants, as position 60 was invari-
antly tryptophan. The most common residues in this set as a
whole were wild-type. However, the identification of 252 vari-
ants that can effectively antagonize ParE3 indicates a substan-598 Cell 163, 594–606, October 22, 2015 ª2015 Elsevier Inc.tial degree of functional degeneracy in the ParD3 interfacial
residues.
Next, to assess the ability of each ParD3 variant to antagonize
the non-cognate toxin ParE2, we repeated the competitive
growth experiment but co-transformed E. coli with our ParD3 li-
brary and an inducible ParE2 vector. As before, we observed
growth rescue following ParD3 library expression with large
changes in the frequency of individual variants over time (Figures
4G and S4E). However, the frequency changes observed here
differed from those observed against the cognate toxin ParE3.
For example, a variant containing the specificity residues found
in the native ParD2 antitoxin, AWIL, was enriched in the ParD3
library screened against ParE2 but was depleted when screened
against ParE3 (Figures 4C and 4H). We quantified variant fitness
as before and found a total of 151 variants (1.6% of the total)
capable of antagonizing ParE2 with W values > 0.5 (Figures 4I
and S4E). The most common residues were Ala59, Trp60
(invariant), Leu61, and Leu64. However, we noted important dif-
ferences between variants reactive against ParE2 and ParE3,
particularly at the last two variable positions in our library.
ParE2-specific variants tended to have small hydrophobic or
positively charged residues at position 61, whereas ParE3-spe-
cific variants favored negatively charged residues at this position
(Figures 4F and 4I). Additionally, ParE2-specific variants were
more likely to contain small hydrophobic residues at position
64, whereas ParE3-specific variants tended to have positively
charged residues (Figures 4F and 4I).
Mutational Paths That Reprogram Specificity Tend
to Involve Promiscuous Variants
Tomore systematically probe the sequence space governing the
specificity of ParD3, we generated a scatterplot of ParD3 variant
fitness when screened against the ParE2 or ParE3 toxin (Fig-
ure 5A). This analysis revealed variants spanning all ranges of
fitness, including those capable of antagonizing ParE2, ParE3,
or both toxins simultaneously. We identified a total of 31 promis-
cuous variants (W > 0.5 for both toxins), which represents a sub-
set of the 252 ParE3-reactive and 151 ParE2-reactive variants
(Figure 5B). We then grouped variants by specificity class (Fig-
ure S5A) and found that the promiscuous variants, such as
LWEL, tended to harbor sequence elements from both ParD3
and ParD2, often with negatively charged residues at position
61 (ParD3-like) and aliphatic residues at position 64 (ParD2-
like) (Figure 5C).
To visualize the connectivity of functional variants in sequence
space, we created a force-directed graph where individual no-
des represent functional variants with lines connecting variants
that differ by a single amino acid (Figure 5D). Node sizes increase
with greater connectivity and node colors represent the speci-
ficity class of a given variant (Figure 5D). The resulting graph
was densely interconnected but generally grouped variants
based on their specificity. The average number of edges per
node, or degree, was 17.8 and ranged from 7 to 31. However,
we noted that the average number of edges per node was
23% higher for promiscuous variants than for variants specific
for ParE2 or ParE3 (Figure 5E). We also generated a force-
directed graph in which edges represent variants that differ by
a single-nucleotide substitution, following the standard genetic
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Figure 4. High-Throughput Mapping of Mutant Fitness at Co-evolving Interface
(A) Composition of the ParD3 antitoxin library at the four variable positions.
(B) Library growth following ParE3 toxin induction.
(C) Frequency changes over time for the indicated ParD3 variants following ParE3 induction.
(D) Testing of individual variants from (C) using the toxicity rescue assay. 10-fold serial dilutions were plated from cultures expressing the ParD3 variant indicated
and the ParE3 toxin.
(E) Two biological replicates of fitness measurements derived from screening the ParD3 library against the ParE3 toxin.
(F) Frequency logo for ParD3 library variants with high fitness against ParE3 (WE3 > 0.5).
(G) Library growth following induction of the non-cognate ParE2 toxin.
(H) Frequency changes over time for the indicated ParD3 library variants.
(I) Frequency logo for ParD3 library variants with high fitness against ParE2 (WE2 > 0.5).
Also see Figure S4.code (Figure S5B). For this graph, promiscuous variants were, on
average, 31% more connected to other nodes than their ParE2-
or ParE3-specific counterparts (Figure 5E). This increased con-nectivity of promiscuous variants was highly significant for
both amino acid and nucleotide graphs, as it was lost when
the edges of each graph were randomly shuffled (p < 104,Cell 163, 594–606, October 22, 2015 ª2015 Elsevier Inc. 599
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Figure 5. Specificity-Reprogramming Paths Are Highly Enriched for Promiscuous Variants
(A) Fitness of ParD3 variants against ParE2 and ParE3. Green, specific for ParE3; blue, capable of antagonizing both ParE2 and ParE3; red, specific for ParE2.
Histograms of fitness values against ParE2 and ParE3 are shown.
(B) Venn diagram of ParD3 variants reactive against ParE3, ParE2, or both.
(C) Frequency logo of promiscuous ParD3 variants (WE2 > 0.5, WE3 > 0.5).
(D) Force-directed graph of all ParD3 variants reactive against ParE3 or ParE2 (W > 0.5). Nodes represent individual variants and edges represent single amino-
acid substitutions. Node size scales with increasing degree and color corresponds to the specificity classes in (A).
(E) Average number of edges per node for the indicated categories of ParD3 variants. Error bars indicate SEM.
(F) Examples of ‘‘switch-like’’ and ‘‘promiscuity-based’’ mutational paths from an E3-specific variant to an E2-specific variant with the fitness against each variant
color-coded based on the scale shown.
(G) Left, percentage of ‘‘switch-like’’ and ‘‘promiscuity-based’’ paths from the wild-type ParD3 sequence (LWDK) to each of the 66 ParE2-specific variants (WE2 >
0.5, WE3 < 0.1). Right, same as left panel but for 10,000 simulations in which the graph edges were randomly shuffled while keeping the total edge count and
degree distribution constant. Error bars represent SEM.
(H) Histogram representing percentage of ‘‘promiscuity-based’’ paths in 10,000 edge shuffling simulations; red line indicates percentage for the observed amino
acid graph.
Also, see Figure S5.
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(A) Mutational paths from LWDK to LWKL for ParD3 with fitness of each variant against ParE2 and ParE3 shown as a heatmap: yellow, high fitness; black low
fitness.
(B) The six path types that reprogram ParD3 specificity in twomutational steps. Percentage of mutational paths in each category is indicated for a threshold of 0.5
used to define a positive interaction.
Also see Figure S6.Figures S5C and S5D). The high connectivity of promiscuous
variants was even more pronounced with a more stringent defi-
nition of specificity (Figure S5E).
The dense connectivity of promiscuous variants suggested
that mutational paths that change ParD3 specificity (from
ParE3-specific to ParE2-specific, or vice versa) tend to travel
through promiscuous intermediates. To test this hypothesis,
we first defined two types of specificity-reprogramming paths.
Note that for the following analysis, we exclude paths in which
ParD3 fails to interact with both ParE3 and ParE2 (also see Dis-
cussion). The first class of paths are ‘‘switch-like’’ and only
involve intermediates that are specific for ParE2 or ParE3,
whereas the second class of paths are ‘‘promiscuity-based’’
and travel through at least one intermediate that can inhibit
both ParE2 and ParE3 (Figure 5F). To determine whether paths
that change the interaction specificity of ParD3 tend to be
switch-like or promiscuity-based, we identified all shortestmuta-
tional paths from the wild-type ParD3 variant (LWDK) to each of
the 66 variants that are highly specific for ParE2 (WE2 > 0.5,WE3 <
0.1; Figure S5A); for this analysis, each mutational step involved
a single amino-acid substitution.We found a total of 370 shortest
paths, of which 40% involved a promiscuous intermediate (Fig-
ure 5G). The percentage of paths via promiscuous intermediates
increased to 61% when considering only paths that involve sin-
gle-nucleotide substitutions (Figure 5G).
To determine whether the number of paths that involve pro-
miscuous variants is greater than would be expected by chance,
we generated graphs in which the edges were randomly shuf-
fled, and again calculated the percentage of each class of paths
from ParD3 (LWDK) to the ParE2 highly specific variants. For
these graphs with randomized edges, the percentage of paths
involving promiscuous intermediates dropped to 15% for the
amino acid neighbor graph and 20% for the nucleotide neighbor
graph (Figures 5G and 5H). Thus, the enrichment of promiscuity-
based paths in the observed graphs is significant (p < 0.005) (Fig-ures 5G, 5H, and S5F). Collectively, our results demonstrate the
dense connectivity of functional variants in the sequence space
governing ParD-ParE interaction specificity and reveal that
specificity-reprogramming paths are highly enriched for those
that involve promiscuous variants, which may facilitate the evo-
lution of ParD-ParE systems with new specificities.
Epistasis: Mutational Order Dictates Specificity Class
of Intermediate Variants
Inspection of the paths connecting ParD3 variants with different
specificities indicated that the third and fourth library positions,
residues 61 and 64 in ParD3, contribute significantly to the insu-
lation of the ParD-ParE system. For instance, the wild-type res-
idue combination in ParD3, LWDK, renders it specific for binding
to ParE3, whereas the double-mutant variant LWKL is specific
for ParE2. Strikingly, however, the two possible paths connect-
ing LWDK and LWKL are in different classes (Figure 6A). A single
ParD3 substitution (K64L in LWDL) resulted in promiscuous
binding to ParE2 and ParE3, whereas a second substitution in
this background (D61K in LWKL) resulted in specificity for
ParE2 (Figure 6A). In contrast, incorporating these substitutions
in the reverse order, D61K and then K64L, resulted in a switch-
like change in specificity in which the initial D61K substitution re-
tained specificity for ParE3, but then enabled the subsequent
K64L substitution to produce a ParE2-specific antitoxin (Fig-
ure 6A). These results underscore how a small number of muta-
tions can fully reprogram protein-protein interaction specificity
and demonstrate that the order of mutations can strongly affect
whether the path to a new specificity state involves a promiscu-
ous intermediate or a rapid switch.
Our finding that changes in specificity can depend strongly on
the order of substitutions represents a form of epistasis, broadly
defined as cases where the functional effect of individual substi-
tutions is context-dependent rather than additive and indepen-
dent (Lehner, 2011). To more broadly quantify this epistasis forCell 163, 594–606, October 22, 2015 ª2015 Elsevier Inc. 601
the ParD3 interfacial residues, we first defined six types of spec-
ificity-reprogramming paths that involve two amino-acid substi-
tutions (Figure 6B). Three of the six path types are epistatic with
the two intermediates having different specificities, implying that
substitution order influences changes fromParE3 to ParE2 spec-
ificity. We quantified the path type for each case in which two
substitutions reprogram ParD3 from being specific for ParE3
(WE3 > 0.5, WE2 < 0.5) to being specific for ParE2 (WE3 < 0.5,
WE2 > 0.5) and found a total of 2,653 such cases, of which
92% were epistatic (Figure 6B). The percentage of epistatic
paths was robust to the threshold used for defining positive inter-
actions (Figures S6A and S6B). Taken together, our results high-
light the pervasive effects of epistasis on ParD function. Although
studies of epistasis typically consider the interdependence of in-
dividual substitutions with respect to protein folding or a single-
protein function (Kondrashov and Kondrashov, 2015; Lehner,
2011), our findings indicate that epistasis can also manifest at
the level of interaction specificity. This form of epistasis may
significantly impact the evolution of new ParD-ParE systems.
Promiscuous intermediates enable a change in protein-protein
interaction specificity without passing through a non-functional
state, in which a liberated toxin would suppress growth and pro-
liferation (Figure 1A). Thus, the epistasis documented here may
fundamentally restrict mutational trajectories during evolution
to those involving promiscuous intermediates.
Mutational Trajectories to an Orthogonal ParD3-ParE3
Pair
Thus far, we have considered changes to one side of the ParD-
ParE interface. To probe how the interaction specificity of a
ParD-ParE protein pair coevolves, we sought to generate a
variant of the toxin ParE3 that does not interact with ParD3,
and then select ParD3 variants from our library that can
neutralize this novel toxin. To this end, we generated a variant
of the toxin, called ParE3*, that retains toxicity but is incapable
of binding to the ParD3 antitoxin. In particular, we mutated five
ParE3 positions (Arg54, Arg58, Ala61, Met63, and Leu72, or
RRAML) that strongly covary with the specificity residues in
ParD3. We mutated RRAML/VEIRF, as each individual variant
residue was frequently observed in ParE3 homologs and was
chemically different from the corresponding wild-type residue
(Figure S7A). As expected, we found that ParE3* retained toxicity
but was no longer neutralized by ParD3 (Figure 7A).
To determine whether variants in the ParD3 library neutralized
ParE3*, we performed a competitive growth experiment
following co-transformation. As before, we converted changes
in variant frequencies to fitness values, which were highly repro-
ducible (R2 = 0.96, Figure S7B). Sequence analysis of the high-
fitness mutants (W > 0.5) revealed large differences in amino-
acid preferences at positions 60 and 61 relative to those shown
above (Figures 4F and 7B). In particular, for the ParD3 variants
that neutralized ParE3*, the invariant Trp60 was replaced by
Ile/Val/Leu and the strong preference for a negatively charged
residue at position 61 was replaced by positively charged or
neutral residues (Figures 4F and 7B). One of the high-fitness var-
iants with specificity residues LIAK, renamed ParD3*, no longer
neutralized ParE3 but robustly interactedwith ParE3* (Figure 7C).
Taken together, our results indicate that mutations in the speci-602 Cell 163, 594–606, October 22, 2015 ª2015 Elsevier Inc.ficity residues of ParD3 and ParE3 are sufficient to create an
orthogonal, interacting protein pair.
Our results indicate that mutational paths leading to a change
in ParD specificity tend to pass through promiscuous intermedi-
ates (Figure 5). Thus, we wanted to determine whether muta-
tional paths between the wild-type ParD3-ParE3 and the orthog-
onal ParD3*-ParE3* systems also pass through promiscuous
intermediates, thereby changing the specificity of both proteins
without disrupting their interaction. We therefore generated var-
iants of ParE3 containing all possible subsets of the substitutions
in ParE3* (32 mutants) and variants of ParD3 containing all
possible subsets of the substitutions in ParD3* (4 mutants). We
then co-transformed each possible pairing of ParD3 and ParE3
variants (128 pairs total) into E. coli and assessed interaction us-
ing the toxicity-rescue assay (Figure 7D). Interestingly, 90 of the
128 pairs of ParD3 and ParE3 variants were capable of interact-
ing, likely becausemost (17 of 32) of the ParE3 variants were pro-
miscuous, which we define as interacting strongly with both
ParD3 and ParD3* (Figure 7D).
To determine whether paths between the wild-type and insu-
lated ParD-ParE pairs tend to pass through promiscuous inter-
mediates, we first enumerated the total number of trajectories
between these systems. Assuming one residue is changed per
step and no reversions are considered, there are 5,040 paths
from ParD3-ParE3 to the orthogonal ParD3*-ParE3* pair; of
these paths, 1,030 retain functionality at each intermediate
step. Strikingly, we found that all of these 1,030 functional paths
passed through at least one promiscuous intermediate of ParE3
with an average of five promiscuous ParE3 intermediates per
path (Figure S7C). The prevalence of these promiscuous states
may enable the ParD-ParE system to readily evolve a new inter-
action specificity. An initial broadening of ParE3 specificity en-
ables the movement of ParD3 in sequence space, followed by
a narrowing of ParE3 specificity in the final step (Figure 7E). By
contrast, mutational paths in which a substitution in either
ParD or ParE yields a ‘‘switch-like’’ change in specificity would,
by definition, be broken until a second substitution restores the
interaction. Thus, our results support the notion that the coevo-
lution and expansion of the ParD-ParE family occurs through
promiscuous intermediates.
DISCUSSION
Mutational Trajectories and the Coevolution
of Protein-Protein Interactions
Interacting proteins coevolve, and the identification of coevolv-
ing amino acids in two proteins can often help to pinpoint the res-
idues that mediate their interaction. Such analyses are typically
predicated on the idea that a mutation in one protein that dis-
rupts an interaction then drives selection of a compensatory mu-
tation in the partner, thereby restoring the interaction (Figure 1A).
However, this model implies that organisms tolerate (at least
transiently) a non-functional, or less functional, interaction,
which seems unlikely if the protein-protein interaction is essential
for viability. Our results provide a solution to this conundrum,
demonstrating experimentally how interacting proteins can
coevolve and acquire new specificity by having one of the pro-
teins pass through a promiscuous intermediate (Figure 1B). For
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Figure 7. Mutational Trajectories to an Orthogonal ParD3*-ParE3* Pair
(A) ParE3* is insulated from antitoxin ParD3. A plasmid containing either ParE3 or ParE3* was co-transformed into E. coli with a plasmid expressing ParD3, and
cells were plated on medium that induces or represses expression of the toxin and antitoxin.
(B) Frequency logo for ParD3 library variants with high fitness against ParE3* (WE3* > 0.5).
(C) ParE3*-ParD3* is insulated from the wild-type ParD3-ParE3 pair.
(D) Toxicity-rescue interaction assays for all ParD3 and ParE3 mutant combinations. Top left, wild-type ParD3-ParE3 pair; bottom right, orthogonal ParD3*-
ParE3* pair. Promiscuous ParE3 intermediates are those capable of interacting with both ParD3 and ParD3*.
(E) Example of a series of single substitutions that lead to the insulated ParE3*-ParD3* system while retaining the toxin-antitoxin interaction at each step by first
expanding the specificity of ParE3, followed by changes in ParD3, and finally by restricting the specificity of ParE3.
Also see Figure S7.instance, a mutation in an antitoxin can initially broaden its spec-
ificity; the toxin can then accumulate a mutation that moves it in
sequence space but retains its interaction with the antitoxin. A
subsequent substitution in the antitoxin can then narrow its
specificity to include the mutated toxin and exclude the original
form. The net result is a change in specificity without disruption
of the protein-protein interaction, which is critical as a disruption
at any step would liberate a toxin that prevents growth and pro-
liferation. This model for protein coevolution involves a minimum
of three instead of twomutations but means that the protein-pro-
tein interaction is functional at each step. Thus, such mutationaltrajectories could be entirely neutral but importantly would
retain a pairwise-coevolution signature in multiple sequence
alignments.
Our systematic identification of ParD3 variants that can antag-
onize ParE3, ParE2, or both revealed an abundance of promiscu-
ous variants in sequence space that are, on average, more highly
connected to other functional variants than are specific variants.
Consequently, the mutational trajectories that reprogram the
specificity of ParD3 frequently involve promiscuous intermedi-
ates (Figures 5F and 5G). The high frequency of mutational
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considering transitions in ParD3 from being specific for ParE3 to
specific for ParE2, and even more so when considering muta-
tions on both sides of the interface. We assessed the complete
set of mutational trajectories between the wild-type ParD3-
ParE3 and the orthogonal ParD3*-ParE3* by testing 128 pairwise
interactions between all possible ParD3 and ParE3mutational in-
termediates. Strikingly, 17 of the 32 ParE3 intermediate variants
were promiscuous, or capable of interacting with both the ParD3
and ParD3* variants (Figure 7). Consequently, all of the functional
paths between ParD3-ParE3 and ParD3*-ParE3* involved at
least one promiscuous intermediate, with most involving more
than five (Figure 7). Our results thus suggest that promiscuous
variants of ParD and ParE are abundant in sequence space
and that promiscuity-enabling mutations can facilitate the evolu-
tion of new interaction specificities while still using the same set
of interfacial residues.
A similar principle may apply to other protein-protein interac-
tions throughout biology, even those not involving toxic proteins.
The disruption of a given protein-protein interaction could pre-
vent the execution of an essential cellular function or lead to an
unwanted, detrimental interaction with another protein, thus fa-
voring coevolutionary trajectories that retain function at each
step. This same principle may also underlie the coevolution of
transcription factors and their DNA binding sites. The evolu-
tionary history of a steroid hormone receptor and its recognition
element was recently reconstructed including the analysis of a
possible ancestral state of the steroid receptor and mutational
intermediates separating it from extant states (Anderson et al.,
2015). Several of the intermediates were promiscuous and may
have facilitated coevolution of the receptor and its recognition
element toward a new specificity without disrupting the interac-
tion. However, that study only considered mutational intermedi-
ates containing residues present in the ancestral or derived
states, and our analyses of the ParD-ParE interface suggest
that promiscuous intermediates can also involve substitutions
that appear in neither the ancestral nor the derived states.
Like many protein families, toxin-antitoxin systems can
expand through duplication and divergence. The duplication of
a toxin-antitoxin system could allow one of the protein pairs to
wander unconstrained in sequence space toward a new interac-
tion specificity via switch-like paths that involve non-functional
intermediates. After a duplication, one antitoxin could accumu-
late interaction-disrupting substitutions while its toxin is still in-
hibited by the other antitoxin. The toxin could then subsequently
mutate to restore an interaction with the derived antitoxin. How-
ever, this scenario assumes that the evolving antitoxin does not,
in the intermediate state, interact inappropriately with other pro-
teins, and it assumes that the other antitoxin is produced at suf-
ficiently high levels to inhibit 2-fold more toxin, i.e., that there is
normally a significant excess of free antitoxin, which may not
be the case. Determining whether and when switch-like or pro-
miscuous paths are followed will require careful reconstructions
of toxin-antitoxin evolution.
High-Throughput Mapping of Protein Interaction
Specificity
Deep mutational scanning via next-generation sequencing is a
relatively new approach for interrogating the relationship be-604 Cell 163, 594–606, October 22, 2015 ª2015 Elsevier Inc.tween protein sequence and function, including folding, enzy-
matic activity, or the binding of a target protein or RNA (Fowler
and Fields, 2014). These studies have begun to reveal the func-
tional degeneracy of proteins by examining all, or nearly all,
possible single mutants of a given protein. Similar approaches
have also been used to probe subsets of all possible double
and higher-order mutants (Melamed et al., 2013) or to systemat-
ically probe all possible mutants at a limited set of positions
(Podgornaia and Laub, 2015).
Deep mutational scans have been focused primarily on how
mutations alter a single function or protein interaction. One study
examined the ability of a PDZ domain to interact with both a
cognate and non-canonical peptide ligand (McLaughlin et al.,
2012), but only queried single-point mutants. However, the inter-
action specificity of a protein is a distributed property of multiple
amino acids, and the prevalence of epistasis means that the
behavior of multiple mutations is difficult to infer from the prop-
erties of the corresponding single mutants. We queried a diverse
library of ParD3 variants harboring multiple mutations of key
specificity residues against two separate proteins: the cognate
toxin ParE3 and the non-cognate toxin ParE2. This focused li-
brary approach was possible as the specificity of ParD is largely
determined by a small number of interfacial residues (Figure 3).
Our approach yielded a high-density map of the sequence
space of ParD3 that underpins its substrate interaction speci-
ficity (Figures 5A–5D). From these data, we uncovered the resi-
dues in ParD3 most responsible for its selective binding of one
toxin over another (Figures 4F and 4I). We found that three posi-
tions (60, 61, and 64) primarily dictate specificity, with substitu-
tions at two sites (61 and 64) sufficient to switch ParD3 from
antagonizing ParE3 to ParE2, and substitutions at an overlap-
ping set of sites (60 and 61) sufficient to switch ParD3 from
antagonizing ParE3 to ParE3*. As noted, our results also demon-
strated the existence of many residue combinations that pro-
mote a promiscuous state of ParD3 or ParE3. Mutations that
render proteins more promiscuous, with respect to catalytic ac-
tivities or binding partners, has been noted anecdotally (Aharoni
et al., 2005; Bloom and Arnold, 2009), but the prevalence of such
states and, importantly, their accessibility from more specific,
wild-type states has never been mapped in a comprehensive
manner.
By building and screening libraries harboring multiple muta-
tions, our work also sheds new light on protein epistasis and
the non-additive relationship of individual substitutions. Epis-
tasis has been well documented but is typically assessed with
respect to a single-protein function. By contrast, the epistasis
documented here for ParD3 pertains to its specificity and inter-
action with two different proteins, revealing interdependencies
that would be missed when considering only a single function.
For instance, consider the example in Figure 6A where ParD3
transitions from the E3-specific residues LWDK to the E2-spe-
cific residues LWKL. With respect to antagonizing the toxin
ParE3, the two single mutants, LWDL and LWKK, are each func-
tional. However, with respect to toxin ParE2, LWDL is functional
whereas LWKK is not, reflecting a non-additive relationship be-
tween the two substitutions leading to the double mutant
LWKL. This type of epistasis may, like other forms of epistasis,
restrict the evolution of ParD-ParE systems, which likely follows
mutational paths that involve promiscuous states, as discussed
above.
Interaction Specificity of Toxin-Antitoxin Systems
The specificity of interactions in bacterial toxin-antitoxin systems
had previously been unclear, with some reports indicating that
these protein-protein interactions are specific (Fiebig et al.,
2010) and others suggesting that TA systems form large,
cross-reactive networks (Yang et al., 2010; Zhu et al., 2010).
Here, by performing a systematic assessment of interaction
specificity for a TA family, we found that ParD antitoxins typically
exhibit an exquisite preference for binding to their co-transcribed
ParE toxins, forming exclusive, cognate pairs. Of 180 non-
cognate pairings tested, we found cross-talk in only 11 cases
(Figure 2) and, importantly, no cross-talk was observed for
non-cognate pairs present in the same species.
The high degree of protein-protein interaction specificity
observed for the ParD-ParE family is similar to that observed
for other large, paralogous protein families (Newman and Keat-
ing, 2003; Skerker et al., 2008; Stiffler et al., 2007; Zarrinpar
et al., 2003). The specificity of many of these paralogous families
has been attributed to selection against detrimental cross-talk
(Capra et al., 2012; Zarrinpar et al., 2003), raising the possibility
that the ParD-ParE family may be under similar selective pres-
sures. However, the biological rationale for maintaining the
specificity of TA systems is unclear, and will require a deeper un-
derstanding of the function of these systems in bacterial
physiology.
Final Perspective
In sum, our work provides a rationale and molecular basis for
how protein interaction specificity can change and how two pro-
teins can coevolve without involving non-functional intermedi-
ates. Mutations that produce promiscuity have been described
for a variety of proteins, but the frequency of such mutations
and their accessibility from more specific states had been un-
clear. Our results indicate that, at least for ParD3 and likely other
proteins, promiscuous mutants are prevalent and easily reached
from the wild-type sequence through a single mutation. The
prevalence of promiscuous intermediates may facilitate the
expansion of toxin-antitoxin systems and, more broadly, other
paralogous protein families.
EXPERIMENTAL PROCEDURES
ParD3-ParE Structure Analysis
For details on the structural analysis of M. opportunistum ParD3 and ParE3,
see Supplemental Experimental Procedures.
Identification of Coevolving Residues
Coevolving residues in the ParDE family were identified using GREMLIN at
http://gremlin.bakerlab.org. Input sequences were ParD3 and ParE3 from
M. opportunistum, and we set the number of iterations to four and the E-value
cutoff to 1E-04. To identify specificity residues, we isolated all residue pairings
that had a scaled coupling score greater than 1.25. To identify supporting res-
idues, we performed the following iterative procedure using a score cutoff of
1.25: (1) identify residues within ParD or ParE that covary with the specificity
residues; (2) identify residues within ParD or ParE that covary with either the
specificity residues or the supporting residues identified in step (1); (3) repeat
step (2) until no new supporting residues are identified.ParD3 Library Construction and Analysis
For details on construction of the ParD3 library, see the Supplemental Exper-
imental Procedures. To assess the ability of each ParD3 variant to antagonize
different ParE toxins, E. coli cells harboring the ParD3 plasmid library were
electroporated with a plasmid containing an arabinose-inducible copy of the
ParE toxin. Cells were grown out overnight in 200 ml M9L supplemented
with 0.4% glucose and antibiotics. The following day, cells were spun down,
washed in 50 ml of M9L, and re-suspended at an OD of 0.03 in 500 ml of
M9L supplemented with 100 mM IPTG (to induce the ParD3 library) and antibi-
otics. Cells were grown out at 37C with shaking for 100 min, and then ParE
toxin expression was induced by the addition of 0.2% arabinose. Cell density
was measured every 20 min and samples (50 ml) were taken every 100 min,
pelleted, and frozen at 20C. Competitive liquid growth assays were per-
formed in duplicate. Plasmid DNA was extracted and used as template for
PCR (20 cycles) with custom barcoded primers containing Illumina flowcell
adaptor sequences. Samples were sequenced on an Illumina HiSeq and
then filtered, counted, and converted to fitness values as described in the Sup-
plemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2015.09.055.
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